BUSINESS
Glenmark Pharmaceuticals rises on getting USFDA’s nod for Sodium Phenylbutyrate Tablets
Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on the BSE. The scrip opened at…